Llovera RE - Search Results

1

Nanoformulation for potential topical delivery of Vismodegib in skin cancer treatment.

Calienni MN, Febres-Molina C, Llovera RE, Zevallos-Delgado C, Tuttolomondo ME, Paolino D, Fresta M, Barazorda-Ccahuana HL, Gómez B, Alonso SDV, Montanari J. Calienni MN, et al. Among authors: llovera re. Int J Pharm. 2019 Jun 30;565:108-122. doi: 10.1016/j.ijpharm.2019.05.002. Epub 2019 May 7. Int J Pharm. 2019. PMID: 31071417

2

Ghrelin binding to serum albumin and its biological impact.

Lufrano D, Trejo SA, Llovera RE, Salgueiro M, Fernandez G, Martínez Damonte V, González Flecha FL, Raingo J, Ermácora MR, Perelló M. Lufrano D, et al. Among authors: llovera re. Mol Cell Endocrinol. 2016 Nov 15;436:130-40. doi: 10.1016/j.mce.2016.07.016. Epub 2016 Jul 16. Mol Cell Endocrinol. 2016. PMID: 27431015

3

The degradation of amyloid beta as a therapeutic strategy in Alzheimer's disease and cerebrovascular amyloidoses.

Morelli L, Llovera R, Ibendahl S, Castaño EM. Morelli L, et al. Neurochem Res. 2002 Nov;27(11):1387-99. doi: 10.1023/a:1021679817756. Neurochem Res. 2002. PMID: 12512943 Review.

4

Biochemical, biophysical, and functional properties of ICA512/IA-2 RESP18 homology domain.

Sosa L, Torkko JM, Primo ME, Llovera RE, Toledo PL, Rios AS, Flecha FL, Trabucchi A, Valdez SN, Poskus E, Solimena M, Ermácora MR. Sosa L, et al. Among authors: llovera re. Biochim Biophys Acta. 2016 May;1864(5):511-22. doi: 10.1016/j.bbapap.2016.01.013. Epub 2016 Feb 1. Biochim Biophys Acta. 2016. PMID: 26836020

5

Effects of point mutations in the binding pocket of the mouse major urinary protein MUP20 on ligand affinity and specificity.

Ricatti J, Acquasaliente L, Ribaudo G, De Filippis V, Bellini M, Llovera RE, Barollo S, Pezzani R, Zagotto G, Persaud KC, Mucignat-Caretta C. Ricatti J, et al. Among authors: llovera re. Sci Rep. 2019 Jan 22;9(1):300. doi: 10.1038/s41598-018-36391-3. Sci Rep. 2019. PMID: 30670733 Free PMC article.

6

Differential degradation of amyloid beta genetic variants associated with hereditary dementia or stroke by insulin-degrading enzyme.

Morelli L, Llovera R, Gonzalez SA, Affranchino JL, Prelli F, Frangione B, Ghiso J, Castano EM. Morelli L, et al. J Biol Chem. 2003 Jun 27;278(26):23221-6. doi: 10.1074/jbc.M300276200. Epub 2003 Apr 14. J Biol Chem. 2003. PMID: 12695513 Free article.

7

Insulin-degrading enzyme in brain microvessels: proteolysis of amyloid {beta} vasculotropic variants and reduced activity in cerebral amyloid angiopathy.

Morelli L, Llovera RE, Mathov I, Lue LF, Frangione B, Ghiso J, Castaño EM. Morelli L, et al. Among authors: llovera re. J Biol Chem. 2004 Dec 31;279(53):56004-13. doi: 10.1074/jbc.M407283200. Epub 2004 Oct 15. J Biol Chem. 2004. PMID: 15489232 Free article.

8

The catalytic domain of insulin-degrading enzyme forms a denaturant-resistant complex with amyloid beta peptide: implications for Alzheimer disease pathogenesis.

Llovera RE, de Tullio M, Alonso LG, Leissring MA, Kaufman SB, Roher AE, de Prat Gay G, Morelli L, Castaño EM. Llovera RE, et al. J Biol Chem. 2008 Jun 20;283(25):17039-48. doi: 10.1074/jbc.M706316200. Epub 2008 Apr 14. J Biol Chem. 2008. PMID: 18411275 Free article.

9

Insulin-degrading enzyme degrades amyloid peptides associated with British and Danish familial dementia.

Morelli L, Llovera RE, Alonso LG, Frangione B, de Prat-Gay G, Ghiso J, Castaño EM. Morelli L, et al. Among authors: llovera re. Biochem Biophys Res Commun. 2005 Jul 8;332(3):808-16. doi: 10.1016/j.bbrc.2005.05.020. Biochem Biophys Res Commun. 2005. PMID: 15913558

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page